• |
  • |
  • |
  • |
Donate

Product

PHARM -- A Placebo-Controlled Pilot Trial of Mecamylamine, a Nicotinic Receptor Agent, in the Treatment of Autism: Introduction of OACIS

Center:
Fiscal Year:
2011
Contact Information:
Product Description:
Keyword(s):
Product/Publication Type(s):
Conference presentations and posters presented
Target Audience:
Professionals
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A